Report cover image

Global Functional Dyspepsia Drug Market Size study, by Indication (Functional Dyspepsia, Organic Dyspepsia), by Drug Type (Proton Pump Inhibitors, H-2-Receptor Antagonists, Antacids, Antibiotics, Prokinetics, Antidepressants), by Medication (Branded Medic

Publisher Bizwit Research & Consulting
Published Jul 17, 2024
Length 200 Pages
SKU # BIZW18997320

Description

Global Functional Dyspepsia Drug Market Size study, by Indication (Functional Dyspepsia, Organic Dyspepsia), by Drug Type (Proton Pump Inhibitors, H-2-Receptor Antagonists, Antacids, Antibiotics, Prokinetics, Antidepressants), by Medication (Branded Medicine, Generic Medicine), by Channel (Over the Counter, Prescription), by Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), and Regional Forecasts 2022-2032


Global Functional Dyspepsia Drug Market is valued approximately at USD 10.52 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 4.92% over the forecast period 2024-2032. Functional dyspepsia is a common disorder that affects the stomach and upper digestive tract. It manifests through symptoms such as pain, discomfort, and bloating, and its exact cause is often difficult to determine. These drugs aim to alleviate symptoms such as bloating, early satiety, and discomfort that occur without any identifiable structural or biochemical abnormalities. Treatment options include proton pump inhibitors (PPIs) to reduce stomach acid production, prokinetic agents to enhance stomach emptying, and medications targeting visceral pain and motility. The goal is to improve quality of life by mitigating symptoms and helping patients better tolerate normal food intake without significant discomfort or pain.

The Global Functional Dyspepsia Drug Market is driven by prevalence of functional dyspepsia is attributed to factors such as dietary changes, increased stress levels, and aging populations and rising healthcare expenditure also plays a crucial role in enhancing access to medical care and pharmacological treatments for functional dyspepsia. Furthermore, the introduction of novel therapies, including prokinetic agents, mucoprotective agents, and neuromodulators, is presenting new opportunities for market growth. However, limited treatment efficacy among patients, and high cost of pharmacological treatments is going to impede the overall demand for the market during the forecast period 2024-2032.

The key regions considered for the Global Functional Dyspepsia Drug Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North America dominated the market share due to the high prevalence of functional dyspepsia and the presence of major pharmaceutical companies investing in research and development. Meanwhile, Asia-Pacific is expected to exhibit the highest growth rate during the forecast period, driven by increasing healthcare expenditure, rising awareness about functional dyspepsia, and the growing availability of advanced treatment options.

Major market players included in this report are:

Abbott Laboratories

Pfizer Inc.

Sanofi SA

Procter & Gamble

Haleon plc

ANI Pharmaceuticals, Inc.

Dr. Reddy’s Laboratories Ltd.

Takeda Pharmaceutical Company Limited

AstraZeneca plc

Salix Pharmaceuticals Inc.

The detailed segments and sub-segment of the market are explained below:

By Indication:
• Functional Dyspepsia
• Organic Dyspepsia

By Drug Type:
• Proton Pump Inhibitors
• H-2-Receptor Antagonists
• Antacids
• Antibiotics
• Prokinetics
• Antidepressants

By Medication:
• Branded Medicine
• Generic Medicine

By Channel:
• Over the Counter
• Prescription

By Distribution Channel:
• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies

By Region:

North America
• U.S.
• Canada

Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE

Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC

Latin America
• Brazil
• Mexico

Middle East & Africa
• Saudi Arabia
• South Africa
• RoMEA

Years considered for the study are as follows:
• Historical year – 2022
• Base year – 2023
• Forecast period – 2024 to 2032

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market

Table of Contents

200 Pages
Chapter 1. Global Functional Dyspepsia Drug Market Executive Summary
1.1. Global Functional Dyspepsia Drug Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Indication
1.3.2. By Drug Type
1.3.3. By Medication
1.3.4. By Channel
1.3.5. By Distribution Channel
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Functional Dyspepsia Drug Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Functional Dyspepsia Drug Market Dynamics
3.1. Market Drivers
3.1.1. Advancements in Diagnosis
3.1.2. Introduction of Novel Therapies
3.1.3. Rising Healthcare Expenditure
3.2. Market Challenges
3.2.1. Limited Treatment Efficacy
3.2.2. High Treatment Costs
3.3. Market Opportunities
3.3.1. Development of Targeted Therapies
3.3.2. Expansion in Emerging Markets
3.3.3. Technological Innovations in Drug Delivery
Chapter 4. Global Functional Dyspepsia Drug Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunity
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Functional Dyspepsia Drug Market Size & Forecasts by Indication 2022-2032
5.1. Segment Dashboard
5.2. Global Functional Dyspepsia Drug Market: Indication Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Functional Dyspepsia
5.2.2. Organic Dyspepsia
Chapter 6. Global Functional Dyspepsia Drug Market Size & Forecasts by Drug Type 2022-2032
6.1. Segment Dashboard
6.2. Global Functional Dyspepsia Drug Market: Drug Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Proton Pump Inhibitors
6.2.2. H-2-Receptor Antagonists
6.2.3. Antacids
6.2.4. Antibiotics
6.2.5. Prokinetics
6.2.6. Antidepressants
Chapter 7. Global Functional Dyspepsia Drug Market Size & Forecasts by Medication 2022-2032
7.1. Segment Dashboard
7.2. Global Functional Dyspepsia Drug Market: Medication Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Branded Medicine
7.2.2. Generic Medicine
Chapter 8. Global Functional Dyspepsia Drug Market Size & Forecasts by Channel 2022-2032
8.1. Segment Dashboard
8.2. Global Functional Dyspepsia Drug Market: Channel Revenue Trend Analysis, 2022 & 2032 (USD Billion)
8.2.1. Over the Counter
8.2.2. Prescription
Chapter 9. Global Functional Dyspepsia Drug Market Size & Forecasts by Distribution Channel 2022-2032
9.1. Segment Dashboard
9.2. Global Functional Dyspepsia Drug Market: Distribution Channel Revenue Trend Analysis, 2022 & 2032 (USD Billion)
9.2.1. Retail Pharmacies
9.2.2. Hospital Pharmacies
9.2.3. Online Pharmacies
Chapter 10. Global Functional Dyspepsia Drug Market Size & Forecasts by Region 2022-2032
10.1. North America Functional Dyspepsia Drug Market
10.1.1. U.S. Functional Dyspepsia Drug Market
10.1.1.1. Indication breakdown size & forecasts, 2022-2032
10.1.1.2. Drug Type breakdown size & forecasts, 2022-2032
10.1.1.3. Medication breakdown size & forecasts, 2022-2032
10.1.1.4. Channel breakdown size & forecasts, 2022-2032
10.1.1.5. Distribution Channel breakdown size & forecasts, 2022-2032
10.1.2. Canada Functional Dyspepsia Drug Market
10.2. Europe Functional Dyspepsia Drug Market
10.2.1. U.K. Functional Dyspepsia Drug Market
10.2.2. Germany Functional Dyspepsia Drug Market
10.2.3. France Functional Dyspepsia Drug Market
10.2.4. Spain Functional Dyspepsia Drug Market
10.2.5. Italy Functional Dyspepsia Drug Market
10.2.6. Rest of Europe Functional Dyspepsia Drug Market
10.3. Asia-Pacific Functional Dyspepsia Drug Market
10.3.1. China Functional Dyspepsia Drug Market
10.3.2. India Functional Dyspepsia Drug Market
10.3.3. Japan Functional Dyspepsia Drug Market
10.3.4. Australia Functional Dyspepsia Drug Market
10.3.5. South Korea Functional Dyspepsia Drug Market
10.3.6. Rest of Asia Pacific Functional Dyspepsia Drug Market
10.4. Latin America Functional Dyspepsia Drug Market
10.4.1. Brazil Functional Dyspepsia Drug Market
10.4.2. Mexico Functional Dyspepsia Drug Market
10.4.3. Rest of Latin America Functional Dyspepsia Drug Market
10.5. Middle East & Africa Functional Dyspepsia Drug Market
10.5.1. Saudi Arabia Functional Dyspepsia Drug Market
10.5.2. South Africa Functional Dyspepsia Drug Market
10.5.3. Rest of Middle East & Africa Functional Dyspepsia Drug Market
Chapter 11. Competitive Intelligence
11.1. Key Company SWOT Analysis
11.1.1. Company 1
11.1.2. Company 2
11.1.3. Company 3
11.2. Top Market Strategies
11.3. Company Profiles
11.3.1. Abbott Laboratories
11.3.1.1. Key Information
11.3.1.2. Overview
11.3.1.3. Financial (Subject to Data Availability)
11.3.1.4. Product Summary
11.3.1.5. Market Strategies
11.3.2. Pfizer Inc.
11.3.3. Sanofi SA
11.3.4. Procter & Gamble
11.3.5. Haleon plc
11.3.6. ANI Pharmaceuticals, Inc.
11.3.7. Dr. Reddy’s Laboratories Ltd.
11.3.8. Takeda Pharmaceutical Company Limited
11.3.9. AstraZeneca plc
11.3.10. Salix Pharmaceuticals Inc.
Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
List of Tables
TABLE 1. Global Functional Dyspepsia Drug market, report scope
TABLE 2. Global Functional Dyspepsia Drug market estimates & forecasts by Region 2022-2032 (USD Billion)
TABLE 3. Global Functional Dyspepsia Drug market estimates & forecasts by Indication 2022-2032 (USD Billion)
TABLE 4. Global Functional Dyspepsia Drug market estimates & forecasts by Drug Type 2022-2032 (USD Billion)
TABLE 5. Global Functional Dyspepsia Drug market estimates & forecasts by Medication 2022-2032 (USD Billion)
TABLE 6. Global Functional Dyspepsia Drug market estimates & forecasts by Channel 2022-2032 (USD Billion)
TABLE 7. Global Functional Dyspepsia Drug market estimates & forecasts by Distribution Channel 2022-2032 (USD Billion)
TABLE 8. Global Functional Dyspepsia Drug market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 9. Global Functional Dyspepsia Drug market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 10. Global Functional Dyspepsia Drug market by segment, estimates & forecasts, 2022-2032 (USD Billion)
This list is not complete, the final report does contain more than 100 tables. The list may be updated in the final deliverable
List of Figures
FIGURE 1. Global Functional Dyspepsia Drug market, research methodology
FIGURE 2. Global Functional Dyspepsia Drug market, market estimation techniques
FIGURE 3. Global market size estimates & forecast methods.
FIGURE 4. Global Functional Dyspepsia Drug market, key trends 2023
FIGURE 5. Global Functional Dyspepsia Drug market, growth prospects 2022-2032
FIGURE 6. Global Functional Dyspepsia Drug market, porters 5 force model
FIGURE 7. Global Functional Dyspepsia Drug market, PESTEL analysis
FIGURE 8. Global Functional Dyspepsia Drug market, value chain analysis
FIGURE 9. Global Functional Dyspepsia Drug market by segment, 2022 & 2032 (USD Billion)
FIGURE 10. Global Functional Dyspepsia Drug market by segment, 2022 & 2032 (USD Billion)
FIGURE 11. Global Functional Dyspepsia Drug market by segment, 2022 & 2032 (USD Billion)
This list is not complete, the final report does contain more than 50 figures. The list may be updated in the final deliverable

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us